Magnolia Medical Technologies Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 61
Employees
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $20M
Latest Deal Amount
  • Investors
  • 14

Magnolia Medical Technologies General Information

Description

Developer of a blood-collection system designed to reduce blood culture sample contamination. The company's system is focused on improving critical processes and technologies to deliver unprecedented efficiency, effectiveness, and optimal patient outcomes, enabling medical professionals to eliminate the preventable error of blood culture contamination and false positive results for sepsis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Outcome Management (Healthcare)
Primary Office
  • 200 West Mercer Street
  • Suite 500
  • Seattle, WA 98119-5908
  • United States
+1 (888) 000-0000

Magnolia Medical Technologies Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Magnolia Medical Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - General 06-May-2020 $20M 000.00 Completed Generating Revenue
5. Debt - PPP 13-Apr-2020 00000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 25-Jan-2019 0000 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series B) 29-Mar-2017 0000 000.00 000.00 Completed Generating Revenue
2. Later Stage VC (Series A1) 28-May-2015 $6.24M $8.75M 000.00 Completed Generating Revenue
1. Later Stage VC (Series A) 30-Aug-2013 $2.51M $2.51M 000.00 Completed Generating Revenue
To view Magnolia Medical Technologies’s complete valuation and funding history, request access »

Magnolia Medical Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A-1 3,055,482 $0.000010 8% $2.04 $2.04 1x $2.04 7.13%
Series A 1,850,809 $0.000010 8% $1.58 $1.58 1x $1.58 4.32%
To view Magnolia Medical Technologies’s complete cap table history, request access »

Magnolia Medical Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a blood-collection system designed to reduce blood culture sample contamination. The company's system is fo
Medical Supplies
Seattle, WA
61 As of 2020
000.00
000000000 000.00

00000 00

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
0000000 00000000
Moline, IL
00000
0000000000 0 00000

000 0000

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000000000 000000000
Tortola, British Virgin Islands
00 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Magnolia Medical Technologies Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Stone Medical Venture Capital-Backed Moline, IL 00000 0000000000 0 00000
000 000000000 Accelerator/Incubator Backed Tortola, British Virgin Islands 00 000000&0
000000000 Corporate Backed or Acquired Lakewood, CO 0000 0000000000
You’re viewing 3 of 3 competitors. Get the full list »

Magnolia Medical Technologies Executive Team (10)

Name Title Board Seat Contact Info
Gregory Bullington Co-Founder, Chief Executive Officer & Board Member
Richard Patton MD Co-Founder, Board Member & Medical Director
Robert Gerberich Chief Commercial Officer
Jay Schwartz Vice President, Business Development & Strategy
Matthew Stuckert Vice President, Sales
You’re viewing 5 of 10 executive team members. Get the full list »

Magnolia Medical Technologies Board Members (11)

Name Representing Role Since
Adam Lessler MD Evidity Health Capital Board Observer 000 0000
Anthony Williams JD Magnolia Medical Technologies Board Observer 000 0000
Garheng Kong Ph.D HealthQuest Capital Board Observer 000 0000
Gregory Bullington Magnolia Medical Technologies Co-Founder, Chief Executive Officer & Board Member 000 0000
Joshua Baltzell SightLine Partners Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Magnolia Medical Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Magnolia Medical Technologies Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
HQ Investments Venture Capital Minority 000 0000 000000 0
RTW Investments Venture Capital Minority 000 0000 000000 0
Evidity Health Capital Growth/Expansion Minority 000 0000 000000 0
Golden Bell Partners Venture Capital Minority 000 0000 000000 0
HealthQuest Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »